Jun 01, 2026
6:5
For every 5 shares held, investors received 6. The price per share adjusted from $25.31 to $21.09.
The split itself did not change the total investment value.
Guangdong Taienkang Pharmaceutical Co., Ltd. Class A (SZSE:301263) operates in the Pharmaceuticals: major industry.
Guangdong Taienkang Pharmaceutical Co., Ltd. Class A company overviewGuangdong Taienkang Pharmaceutical Co., Ltd. Class A's most recent stock split was on June 1, 2026. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.
Guangdong Taienkang Pharmaceutical Co., Ltd. Class A (SZSE:301263) has split its stock 2 times: a 9-for-5 split on May 29, 2023 and a 6-for-5 split on June 1, 2026.
Guangdong Taienkang Pharmaceutical Co., Ltd. Class A has split its stock 2 times. This history records 2 forward splits between May 29, 2023 and June 1, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Guangdong Taienkang Pharmaceutical Co., Ltd. Class A's 6-for-5 split on June 1, 2026, every 5 shares became 6 shares.
Guangdong Taienkang Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 1, 2026, less than a year ago. Companies announce splits in advance, and any new SZSE:301263 split will appear on this page.
Already premium?